Genovis AB Sustainability Reports

Genovis AB develops, manufactures, and markets innovative enzyme tools known as SmartEnzymes for the global biopharmaceutical industry. Its products are primarily used to facilitate, streamline, and improve workflows in the analytical characterization, quality control, and development of biological drugs and therapeutics.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 549300T5KGFRYR7ZST20

FIGI: BBG001SPCYT2

13 reports from 2011 to 2025

• Genovis AB 2025 Annual Report
• Genovis AB 2024 Annual Report
• Genovis AB 2023 Annual Report
• Genovis AB 2022 Annual Report
• Genovis AB 2021 Annual Report